Efficacy of doxycycline as an add on therapy in drug sensitive cavitary pulmonary tuberculosis patients- A randomized placebo controlled trial - NI

Jawaharlal Institute of Postgraduate Medical Education & Research0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年1月22日

研究概览

暂无简介。

•Females (who have completed their family or undergone sterilization)and males- who were newly diagnosed clinically and microbiologically confirmed drug sensitive pulmonary tuberculosis patients who have been receiving anti-tubercular
•therapy for = 7days or about to start standard
•ATT with chest X-Ray demonstrating pulmonary
•cavity/cavities

•Patients with extra pulmonary tuberculosis, previous history of pulmonary TB, HIV coinfections, severe preexisting lung diseases
•(such as fibrosis, COPD, lung cancer, bronchiectasis) and autoimmune diseases
•Patients with ALT/ AST >3 times upper limit of
•Patients with Creatinine > 2 times upper limit of
•Patient on antiepileptic therapy
•Known hypersensitivity to tetracyclines
•Patients who have taken tetracycline in the past
•30 days preceding the dosing of study drug
•Patient who participated in other clinical trials in past 180 days

发起方

Jawaharlal Institute of Postgraduate Medical Education & Research